Navigation Links
AMDL, Inc. Promotes CFO Akio Ariura to Chief Operating Officer and Expands Management Team
Date:11/6/2008

TUSTIN, Calif., Nov. 6 /PRNewswire-FirstCall/ -- (http://www.amdl.com) AMDL, Inc. (Amex: ADL), today announced the promotion of its CFO, Mr. Akio Ariura, to Chief Operating Officer (COO) and CFO. The Company is also expanding its management team with the addition of Mr. Christopher Gee as Director of International Marketing and Sales and Mr. Raymond Gatchalian as Director of Compliance and Information Technology.

As COO and CFO, Mr. Ariura will lead the day-to-day operations of AMDL, including direct responsibility for AMDL's legal, financial, and business affairs; employee development and recruiting; and high-priority companywide initiatives, including the implementation of its Kingdee ERP accounting system within the US and China; joint venture and partnership implementations; and the development of brand and product commercialization strategies across all business divisions.

"I am extremely pleased with the Board's decision to promote Akio to Chief Operating Officer of AMDL," said Mr. Douglas MacLellan, CEO and Chairman, AMDL. "He has been instrumental in the Company's success to date, and broadening his role is a next step as we continue to grow and expand our business. With the support of his leadership and business expertise, AMDL is on-target to meet its gross revenue targets of $30 million to $38 million this year. I'm genuinely excited to have Akio in this newly created senior executive position as we focus on building AMDL as a world-class and market-leading, diversified pharmaceutical company."

Mr. Ariura joined AMDL in 2006 as the Chief Financial Officer. He holds more than 20 years of experience in senior finance and business operations positions with various public and private companies. Mr. Ariura is a certified public accountant and recognized as a Small-Cap SOX compliance expert.

"I'm pleased to transition to this role during such a defining time in AMDL's history. With nearly 500% annual growth over the past three years we've managed to thrive and evolve, despite market uncertainty and recent economic instability," commented Mr. Ariura. "In fact, what I am most proud of is how we've continued to expand our sales and distribution throughout China, with top-line sales that far exceed goals set during our 2007 planning cycle."

AMDL is also expanding its senior management team with the appointment of Mr. Christopher Gee as Director of International Marketing and Sales and Mr. Raymond Gatchalian as Director of Compliance and Information Technology.

Mr. MacLellan continued, "This latest round of executive appointments further complements the top-notch team we have assembled. They are highly qualified, dedicated professionals with the depth of experience and professional tenure to help take AMDL to the next level. I'm pleased to welcome Chris and Ray aboard."

Mr. Gee is a former Apple Inc. executive and tech/biotech industry veteran with extensive IT, business operations, and international sales and marketing management experience. Since 2004 he has held executive positions and worked on projects in the USA, PRC China, Hong Kong, and Taiwan including IT management, product development, marketing, sales and distribution. His oversight spanned US and Asian business operations. His background includes three years as a senior analyst at New York University, Stern School of Business. Mr. Gee has also been a principal in various start-up companies. While at Apple Inc., Mr. Gee successfully managed business development and enterprise computing projects. Mr. Gee holds a Masters degree from Kings College, University of London and a Bachelors degree from New York University.

Mr. Gatchalian has an extensive background in IT audit and compliance. He has worked for both large and small companies including Pacificare Health Systems, Corinthian Colleges and Fremont Investment and Loan and as a consultant with Deloitte & Touche, Jefferson Wells, Countrywide Financial and Diagnostics Products International, with the primary responsibility of planning, conducting and managing system audits and providing consulting services to various IT organizations. Mr. Gatchalian received his B.S. in Computer Information Systems from the DeVry Institute of Technology.

About AMDL:

Headquartered in Tustin, CA with operations in Shenzhen, Jiangxi, and Jilin, China, AMDL, Inc., along with its subsidiary Jade Pharmaceutical Inc. (JPI), is a vertically integrated bio-pharmaceutical company devoted to the research, development, manufacturing, and marketing of diagnostic, pharmaceutical, nutritional supplement, and cosmetic products. The company employs approximately 320 people in the U.S. and China. The Company has an additional 4 pharmaceutical and diagnostic products under review by various regulatory authorities.

Forward Looking Statements:

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements contained in this document include certain predictions and projections that may be considered forward- looking statements under securities law. These statements involve a number of important risks and uncertainties that could cause actual results to differ materially including, but not limited to, the performance of joint venture partners, as well as other economic, competitive and technological factors involving the Company's operations, markets, services, products, and prices. With respect to AMDL, Inc., except for the historical information contained herein, the matters discussed in this document are forward-looking statements involving risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. Potential risks and uncertainties related to the Company's access to additional capital, competition and dependence on key management.

AMDL Contact:

Kristine Szarkowitz

Director-Investor Relations

kszarkowitz@amdl.com

(M) (206) 310-5323


'/>"/>
SOURCE AMDL, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. AMDL, Inc. Retains Strategic Growth International Inc. as its Global Investor Relations Advisor
2. Rudd Report Highlights AMDL, Inc.s Latest Business Achievements; Supports 2008 Financial Guidance
3. The Wall Street Transcript Interviews AMDL, Inc. CEO & President Gary Dreher for Fall Healthcare Issue
4. AMDL, Inc. Closes Private Placement of Convertible Notes
5. AMDL, Inc. to Present at Maxim Group Growth Conference October 7, 2008
6. AMDL, Inc. Announces Strategic Realignment
7. AMDL, Inc. Named to Deloitte LLC Technology Fast 50
8. AMDL, Inc.s President & CEO Mr. Gary Dreher Retires
9. AMDL, Inc. Names Douglas MacLellan as Executive Chairman & CEO
10. Enzyme promotes fat formation
11. Dendreon Promotes Dr. Mark Frohlich to Senior Vice President of Clinical Affairs and Chief Medical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... , ... February 10, 2016 , ... ... three states, announced today the promotion of two long-standing principal investigators (PI) to ... Family Medicine, Clinical Research and Development. , Dr. Laurence Chu, a Benchmark Research ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... on Microsoft Azure. On Azure, Arvados provides capabilities for managing and processing genomic ... for Microsoft Azure from major institutions collecting and analyzing genomic data,” said Adam ...
(Date:2/9/2016)... 2016  Regenicin, Inc. (OTC Bulletin Board: ... development and commercialization of regenerative cell therapies to ... recently reported the Company,s operating results for 2015 ... Lonza America , Inc. (the "Lonza ... in the process of consummating an agreement to ...
(Date:2/9/2016)... ... February 09, 2016 , ... The American Academy of Thermology ... offering its 2016 AAT Member Certification Qualification Course for Technicians via a two part ... which will include a detailed review of hardware, software, and camera setup/operations, aligns with ...
Breaking Biology Technology:
(Date:1/28/2016)... SYNA ), a leading developer of human interface solutions, today ... --> --> Net revenue ... to the comparable quarter last year to $470.5 million. Net income ... $0.93 per diluted share. --> ... 2016 grew 9 percent over the prior year period to $60.3 ...
(Date:1/25/2016)... Pa. , Jan. 25, 2016   Unisys Corporation ... system at John F. Kennedy (JFK) International Airport, New ... Protection (CBP) identify imposters attempting to enter the ... not belong to them. pilot testing of the ... initially at three terminals at JFK during January 2016. --> ...
(Date:1/22/2016)... 2016 http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ... the  "Global Behavioral Biometric Market 2016-2020" ... http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) has announced the ... Market 2016-2020"  report to their offering. ... http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) has announced the addition ...
Breaking Biology News(10 mins):